Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Halozyme Therapeutics Inc...

    NASDAQ: HALO · Real-Time Price · USD
    53.84
    1.04 (1.97%)
    At close: Jun 24, 2025, 3:59 PM

    Halozyme Therapeutics Revenue

    Halozyme Therapeutics reported an annual revenue of $1.02B, reflecting a 22.44% growth. For the quarter ending March 31, 2025, Halozyme Therapeutics generated $264.86M in revenue.
    Revenue (ttm)
    $1.02B
    Revenue Growth
    22.44%
    Price / Sales Ratio
    5.97
    Revenue / Employee
    $2.9M
    Employees
    350
    Market Cap
    6.63B

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist